Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

648 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sclerochoroidal calcification.
Schachat AP, Robertson DM, Mieler WF, Schwartz D, Augsburger JJ, Schatz H, Gass JD. Schachat AP, et al. Among authors: robertson dm. Arch Ophthalmol. 1992 Feb;110(2):196-9. Arch Ophthalmol. 1992. PMID: 1736866
Treatment choice and quality of life in patients with choroidal melanoma.
Cruickshanks KJ, Fryback DG, Nondahl DM, Robinson N, Keesey U, Dalton DS, Robertson DM, Chandra SR, Mieler WF, Zakov ZN, Custer PL, Del Priore LV, Albert DM. Cruickshanks KJ, et al. Among authors: robertson dm. Arch Ophthalmol. 1999 Apr;117(4):461-7. doi: 10.1001/archopht.117.4.461. Arch Ophthalmol. 1999. PMID: 10206573 Clinical Trial.
Subretinal fibrosis in central serous chorioretinopathy.
Schatz H, McDonald HR, Johnson RN, Chan CK, Irvine AR, Berger AR, Folk JC, Robertson DM. Schatz H, et al. Among authors: robertson dm. Ophthalmology. 1995 Jul;102(7):1077-88. doi: 10.1016/s0161-6420(95)30908-6. Ophthalmology. 1995. PMID: 9121756
Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No. 25.
Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, Hawkins BS, Hayman JA, Jaiyesimi I, Kirkwood JM, Koh WJ, Robertson DM, Shaw JM, Straatsma BR, Thoma J; Collaborative Ocular Melanoma Study Group. Diener-West M, et al. Among authors: robertson dm. Arch Ophthalmol. 2005 May;123(5):601-4. doi: 10.1001/archopht.123.5.601. Arch Ophthalmol. 2005. PMID: 15883277 Clinical Trial.
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.
Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, Hawkins BS, Hayman JA, Jaiyesimi I, Jampol LM, Kirkwood JM, Koh WJ, Robertson DM, Shaw JM, Straatsma BR, Thoma J; Collaborative Ocular Melanoma Study Group. Diener-West M, et al. Among authors: robertson dm. Arch Ophthalmol. 2005 Dec;123(12):1639-43. doi: 10.1001/archopht.123.12.1639. Arch Ophthalmol. 2005. PMID: 16344433
The long-term outcome of central serous chorioretinopathy.
Yap EY, Robertson DM. Yap EY, et al. Among authors: robertson dm. Arch Ophthalmol. 1996 Jun;114(6):689-92. doi: 10.1001/archopht.1996.01100130681007. Arch Ophthalmol. 1996. PMID: 8639079 Clinical Trial.
648 results